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Commentary Open Access
New discoveries in medicine are required to understand the 
importance of appetite regulation that is associated with the 
overconsumption of foodin Type 2 and Type 3 diabetes. Food 
restriction in diabetes is essential to maintain the hepatic metabolism 
of dietary fat with relevance to defective post-prandial lipid 
metabolism and to the global non alcoholic fatty liver disease (NAFLD) 
epidemic [1,2]. Premature brain aging has become important with 
the development of Type 3 diabetesand Alzheimer’s disease [3] that 
is associated with  repression of the anti-aging gene Sirtuin 1 (Sirt 1) 
relevant topost-prandial lipid metabolism, amyloid beta metabolism 
(peptide involved in amyloid beta plaques)and circadian rhythm 
abnormalities in the brain biological clock associated with the 
development of NAFLD.Nutritional interventions such as very low 
carbohydrate diets have become important to diabetes (Figure 1) to 
reverse defective post-prandial lipid and amyloid beta metabolism 
without atherogenic lipoprotein formation [4,5] with the prevention 
of accelerated atherosclerosis in various communities. Western diets 
that are high in fat and glucose are linked to diabetes and NAFLD 
with anti-aging geneSirt 1 transcriptional dysregulation [6] in cell and 
tissues associated with, hyperglycemia, mitochondrial apoptosis and 
delayed hepatic fat and amyloid beta metabolism (Figure 1).
Accelerated aging that disturbs the brain to liver crosstalk [6,7] 
involves the calorie sensitive gene Sirtuin 1 (Sirt 1) that is a nicotinamide 
adenine dependent dinucleotide class III histone deacetylase involved 
in the prevention of defective post-prandial metabolism and  NAFLD 
[8-10]. The intake of fat is sensitive to the regulation of the heat 
shock gene Sirt 1 that is responsible for the metabolism of heat shock 
proteins(HSP) [3] that are produced by living cells in response to 
temperature regulation above physiological levels [11, 12]. Heat shock 
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proteins facilitate the rapid metabolism by the liver of amyloid beta 
by preventing its misfolding and aggregation in the brain [3,13,14]. 
Sirt 1 is also sensitive to α-synuclein metabolism [15] and relevant 
to temperature alterations in α-synuclein oligomer and amyloid beta 
formation [16, 17].
Down regulation of Sirt 1 expression and activity disturbs the 
nuclear and mitochondria interactions with effects on the metabolism 
of fatty acids, glucose and amyloid beta metabolism in diabetes [16, 
17]. Heat shock protein (HSP) induces endoplasmic reticulum stress 
(ER) stress with delayed metabolism of amyloid beta/ α-synuclein 
oligomers associated with liver disease linked to NAFLD and 
neurodegenerative diseases. ER stress is associated with programmed 
cell death with relevance to mitochondrial apoptosis, defective post-
prandial lipid metabolism and NAFLD [18-22] with Sirt 1 regulation 
of PGC1 associated with mitochondrial biogenesis after ingestion 
of various fat diets. Sirt 1 regulates HSP by deacetylation of heat 
shock factor (HSF) via peroxisome proliferator-activated receptor 
gamma co activator 1-alpha(PGC1α) as a critical repressor of HSF1-
mediated transcriptional programs [23,24]. Sirt 1 is involved in body 
temperature regulation of the mammalian target of rapamycin(mTOR) 
signaling through the tumor suppressor tuberous sclerosis complex 
1 with relevance to the expression of hepatic PGC-1α and fibroblast 
growth factor 21 (FGF21)  [25-29].
Sirt 1 regulation of cell senescence in diabetes involves cell ontogeny 
with transcriptional ontogeny defective via the transcriptional factor 
p53 involved in the regulation of various other anti-aging genes 
[30-35] such as klotho, p66shc, FOXO3a, micro RNA 34a [18] 
and transcription factors involve post-prandial lipid metabolism, 
metabolic activity, insulin resistance, cellular ontogeny, inflammation 
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Figure 1: In diabetes and neurodegenerative diseases nutritional 
interventions are required to activate the anti-aging gene Sirt 1 and 
prevent defective liver lipid metabolism (NAFLD) and amyloid beta 
metabolism. Diets that are low in fat such as very low carbohydrate 
diets activate the calorie sensitive gene Sirt 1 with glucose metabolism 
connected to accelerated hepatic lipid/amyloid beta metabolism in 
diabetes and neurodegenerative diseases.
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and xenobiotic metabolism[18,36] (Figure 2). In the developing and 
developed world diabetic treatment has become important with 
defective Sirt 1 gene expression determined by miR-34a [18, 36] 
related to defective cell proliferation in the brain and the liver (Figure 
2). Defective thermoregulation may be relevant to ingestion of food 
(Sirt 1 defective)with inappropriate post-prandial lipid and amyloid 
beta metabolism that inactivate magnesium therapy that may now 
be relevant to HSP and amyloid beta metabolism with relevance to 
myocardial infarction [3,37].
Food restriction and fasting regulate Sirt 1 and FGF21 involved in 
the prevention of the metabolic syndrome and maintenance of high 
density lipoprotein levels [39-41]. FGF21 therapy [42, 43] in Type 
2 and Type 3 diabetes may be ineffective with the development of 
cardiac ageing with relevance to core body temperature regulation that 
is determined by mi-34a/Sirt 1 gene expression with low adiponectin 
levels [36,44] (Figure 2). Healthy diets that maintain Sirt 1 activity in 
the brain and liver have become important to many diabetics in the 
developing and developed world with relevance to food technology 
that involve the hepatic metabolism of bacterial lipopolysaccharides 
(LPS) that has become important to the reversal of Type 2 diabetes 
and Type 3 diabetes [45, 46]. Plasma LPS and xenobiotic levels 
[47] have risen in various developed countries and consumption 
of activators such as leucine, pyruvic acid and magnesium may 
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supersede LPS inhibition of Sirt 1 [18, 37] with prevention of defective 
cell transcriptional ontogeny and membrane transformations in the 
brain and liver [45, 46]. Appetite dysregulation in diabetes may require 
these activators of Sirt 1 with relevance to the maintenance of neurons 
and the treatment of Type 3 diabetes with defective apelinergic system 
that involves thermo dysregulation.
Conclusion
Dyslipidemia is one of the key risk factors for cardiovascular disease 
in diabetes. The management of dyslipidemia in diabetes continues to 
remain controversial and improvements in the characteristic diabetic 
dyslipidemia of high triglyceride and low HDL may not indicate 
that defective cell ontogeny is underway early in life. Diabetes and 
defective hepatic cell transcriptional programs induce delayed post-
prandial lipid metabolism associated with Western diets rich in fat and 
glucose. The clinical management of diabetes in the young and elderly 
now not only involves appetite regulation with calorie restricted diets 
that maintain the heat shock gene Sirt 1 expression but also careful 
core body temperature (37°C) to activate hepatic and brain Sirt 1. The 
biological active release of FGF21 is connected to Sirt 1 activation 
and glucose homeostasis with relevance to treatment of dyslipidemia, 
NAFLD, cardiovascular disease and neurodegenerative diseases. 
Consumption of Sirt 1 inhibitors such as alcohol, suramin and 
palmitic acid should be avoided to prevent defective liver and brain 
cell ontogeny in the young and the elderly to prevent hyperglycemia 
induced oxidative stress and myocardial infarction.
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